Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 21

1.

Metalloprotease-mediated cleavage of PlexinD1 and its sequestration to actin rods in the motoneuron disease spinal muscular atrophy (SMA).

Rademacher S, Verheijen BM, Hensel N, Peters M, Bora G, Brandes G, Vieira de Sá R, Heidrich N, Fischer S, Brinkmann H, van der Pol WL, Wirth B, Pasterkamp RJ, Claus P.

Hum Mol Genet. 2017 Oct 15;26(20):3946-3959. doi: 10.1093/hmg/ddx282.

PMID:
29016853
2.

Genetic variants and clinical relevance associated with gestational diabetes mellitus in Chinese women: a case-control study.

Yan J, Su R, Ao D, Wang Y, Wang H, Yang H.

J Matern Fetal Neonatal Med. 2018 Aug;31(16):2115-2121. doi: 10.1080/14767058.2017.1336225. Epub 2017 Jun 14.

PMID:
28554271
3.

Post-endocytic sorting of Plexin-D1 controls signal transduction and development of axonal and vascular circuits.

Burk K, Mire E, Bellon A, Hocine M, Guillot J, Moraes F, Yoshida Y, Simons M, Chauvet S, Mann F.

Nat Commun. 2017 Feb 22;8:14508. doi: 10.1038/ncomms14508.

4.

An Electrical Impedance-Based Method for Quantitative Real-Time Analysis of Semaphorin-Elicited Endothelial Cell Collapse.

Camillo C, Gioelli N, Bussolino F, Serini G.

Methods Mol Biol. 2017;1493:195-207.

PMID:
27787852
5.

Semaphorin 4A enhances lung fibrosis through activation of Akt via PlexinD1 receptor.

Peng HY, Gao W, Chong FR, Liu HY, Zhang JI.

J Biosci. 2015 Dec;40(5):855-62.

PMID:
26648031
6.

Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.

Mazzotta C, Romano E, Bruni C, Manetti M, Lepri G, Bellando-Randone S, Blagojevic J, Ibba-Manneschi L, Matucci-Cerinic M, Guiducci S.

Arthritis Res Ther. 2015 Aug 21;17:221. doi: 10.1186/s13075-015-0749-4.

7.

De novo mutations in PLXND1 and REV3L cause Möbius syndrome.

Tomas-Roca L, Tsaalbi-Shtylik A, Jansen JG, Singh MK, Epstein JA, Altunoglu U, Verzijl H, Soria L, van Beusekom E, Roscioli T, Iqbal Z, Gilissen C, Hoischen A, de Brouwer APM, Erasmus C, Schubert D, Brunner H, Pérez Aytés A, Marin F, Aroca P, Kayserili H, Carta A, de Wind N, Padberg GW, van Bokhoven H.

Nat Commun. 2015 Jun 12;6:7199. doi: 10.1038/ncomms8199.

8.

Positive regulation of neocortical synapse formation by the Plexin-D1 receptor.

Wang F, Eagleson KL, Levitt P.

Brain Res. 2015 Aug 7;1616:157-165. doi: 10.1016/j.brainres.2015.05.005. Epub 2015 May 11.

9.

Plexin D1 determines body fat distribution by regulating the type V collagen microenvironment in visceral adipose tissue.

Minchin JE, Dahlman I, Harvey CJ, Mejhert N, Singh MK, Epstein JA, Arner P, Torres-Vázquez J, Rawls JF.

Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4363-8. doi: 10.1073/pnas.1416412112. Epub 2015 Mar 23.

10.

An image-based RNAi screen identifies SH3BP1 as a key effector of Semaphorin 3E-PlexinD1 signaling.

Tata A, Stoppel DC, Hong S, Ben-Zvi A, Xie T, Gu C.

J Cell Biol. 2014 May 26;205(4):573-90. doi: 10.1083/jcb.201309004. Epub 2014 May 19.

11.

Isolated truncus arteriosus associated with a mutation in the plexin-D1 gene.

Ta-Shma A, Pierri CL, Stepensky P, Shaag A, Zenvirt S, Elpeleg O, Rein AJ.

Am J Med Genet A. 2013 Dec;161A(12):3115-20. doi: 10.1002/ajmg.a.36194. Epub 2013 Oct 29.

PMID:
24254849
12.

Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers.

Luchino J, Hocine M, Amoureux MC, Gibert B, Bernet A, Royet A, Treilleux I, Lécine P, Borg JP, Mehlen P, Chauvet S, Mann F.

Cancer Cell. 2013 Nov 11;24(5):673-85. doi: 10.1016/j.ccr.2013.09.010. Epub 2013 Oct 17.

13.

Plexin D1: new potential biomarker for cervical cancer.

Shalaby MA, Hampson L, Oliver A, Hampson I.

J Immunoassay Immunochem. 2012;33(3):223-33. doi: 10.1080/15321819.2011.634472.

PMID:
22738647
14.

Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.

Sakurai A, Jian X, Lee CJ, Manavski Y, Chavakis E, Donaldson J, Randazzo PA, Gutkind JS.

J Biol Chem. 2011 Sep 30;286(39):34335-45. doi: 10.1074/jbc.M111.259499. Epub 2011 Jul 27.

15.

Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer.

Tseng CH, Murray KD, Jou MF, Hsu SM, Cheng HJ, Huang PH.

PLoS One. 2011 Apr 29;6(4):e19396. doi: 10.1371/journal.pone.0019396.

16.

Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice.

Fukushima Y, Okada M, Kataoka H, Hirashima M, Yoshida Y, Mann F, Gomi F, Nishida K, Nishikawa S, Uemura A.

J Clin Invest. 2011 May;121(5):1974-85. doi: 10.1172/JCI44900. Epub 2011 Apr 18.

17.

Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.

Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I, Risio M, Trusolino L, Weitz J, Schneider M, Mazzone M, Comoglio PM, Tamagnone L.

J Clin Invest. 2010 Aug;120(8):2684-98. doi: 10.1172/JCI42118. Epub 2010 Jul 26. Erratum in: J Clin Invest. 2011 Jul 1;121(7):2945. Mazzone, Massimilano [corrected to Mazzone, Massimiliano].

18.

Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.

Sakurai A, Gavard J, Annas-Linhares Y, Basile JR, Amornphimoltham P, Palmby TR, Yagi H, Zhang F, Randazzo PA, Li X, Weigert R, Gutkind JS.

Mol Cell Biol. 2010 Jun;30(12):3086-98. doi: 10.1128/MCB.01652-09. Epub 2010 Apr 12.

19.

Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies.

Roodink I, Verrijp K, Raats J, Leenders WP.

BMC Cancer. 2009 Aug 25;9:297. doi: 10.1186/1471-2407-9-297.

20.

Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression.

Roodink I, Kats G, van Kempen L, Grunberg M, Maass C, Verrijp K, Raats J, Leenders W.

Am J Pathol. 2008 Dec;173(6):1873-81. doi: 10.2353/ajpath.2008.080136. Epub 2008 Oct 30.

Supplemental Content

Support Center